PLA1A
Phospholipase A1 member A
Also known as: PLA1A_HUMAN, ps-PLA1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53H76
- Gene
- PLA1A
- Ensembl
- ENSG00000144837
- Chromosome
- 3
- Canonical length
- 456 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
The protein encoded by this gene is a phospholipase that hydrolyzes fatty acids at the sn-1 position of phosphatidylserine and 1-acyl-2-lysophosphatidylserine. This secreted protein hydrolyzes phosphatidylserine in liposomes. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2011]
Canonical amino-acid sequenceUniProt
456 residues, UniProt reviewed canonical sequence.
>Q53H76|PLA1A
1 MPPGPWESCF WVGGLILWLS VGSSGDAPPT PQPKCADFQS ANLFEGTDLK VQFLLFVPSN
61 PSCGQLVEGS SDLQNSGFNA TLGTKLIIHG FRVLGTKPSW IDTFIRTLLR ATNANVIAVD
121 WIYGSTGVYF SAVKNVIKLS LEISLFLNKL LVLGVSESSI HIIGVSLGAH VGGMVGQLFG
181 GQLGQITGLD PAGPEYTRAS VEERLDAGDA LFVEAIHTDT DNLGIRIPVG HVDYFVNGGQ
241 DQPGCPTFFY AGYSYLICDH MRAVHLYISA LENSCPLMAF PCASYKAFLA GRCLDCFNPF
301 LLSCPRIGLV EQGGVKIEPL PKEVKVYLLT TSSAPYCMHH SLVEFHLKEL RNKDTNIEVT
361 FLSSNITSSS KITIPKQQRY GKGIIAHATP QCQINQVKFK FQSSNRVWKK DRTTIIGKFC
421 TALLPVNDRE KMVCLPEPVN LQASVTVSCD LKIACVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLA1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 131 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 131 nTPM
- choroid plexus: 86 nTPM
- seminal vesicle: 63 nTPM
- parathyroid gland: 62 nTPM
- liver: 37 nTPM
- lung: 21 nTPM
Single-cell type
- epididymal principal cells: 102 nCPM
- epididymal efferent duct absorptive cells: 92 nCPM
- thymic myoid cells: 82 nCPM
- choroid plexus epithelial cells: 58 nCPM
- hepatocytes: 38 nCPM
- retinal pigment epithelial cells: 30 nCPM
Immune cell
- T-reg: 0.2 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- choroid plexus: 34 nTPM
- thalamus: 12 nTPM
- spinal cord: 8.9 nTPM
- pons: 8.6 nTPM
- medulla oblongata: 8.5 nTPM
- hippocampal formation: 7.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PLA1A.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 79 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.24
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.29
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lipid catabolic process
- lipid metabolic process
- phosphatidylserine acyl-chain remodeling
- phosphatidylserine metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLA1A as an antibody target. Whether an autoantibody or antibody against PLA1A could matter depends on whether native PLA1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLA1A is annotated as secreted, so native PLA1A circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PLA1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...